IFNA1 and metastatic neoplasm: However, the role of IFN is becoming increasingly important, especially in the context of anti-PD-1 therapy, since the initial response to ICIs is associated with a pre-existing IFN-mediated immune activation, which includes the expression of MHC-2 in metastatic tumors [249,250].